Vincent R Anicetti insider trades: Coherus BioSciences (CHRS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vincent reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | CHRS | ↓ Sell | 26,649 | $15.46 | $412K | Direct | Mar 9, 2021 (4d) |
| Feb 17, 2021 | CHRS | ↓ Sell | 2,488 | $17.45 | $43K | Direct | Feb 19, 2021 (2d) |
| Jan 19, 2021 | CHRS | ↓ Sell | 2,500 | $17.94 | $45K | Direct | Jan 21, 2021 (2d) |
| Dec 17, 2020 | CHRS | ↓ Sell | 2,500 | $17.51 | $44K | Direct | Dec 21, 2020 (4d) |
| Dec 7, 2020 | CHRS | ↓ Sell | 8,791 | $18.42 | $162K | Direct | Dec 9, 2020 (2d) |
| Dec 4, 2020 | CHRS | ↓ Sell | 98,756 | $18.76 | $1.9M | Direct | Dec 7, 2020 (3d) |
| Nov 18, 2020 | CHRS | ↓ Sell | 22,770 | $17.72 | $404K | Direct | Nov 19, 2020 (1d) |
| Oct 19, 2020 | CHRS | ↓ Sell | 3,217 | $17.89 | $58K | Direct | Oct 21, 2020 (2d) |
| Sep 17, 2020 | CHRS | ↓ Sell | 5,000 | $18.84 | $94K | Direct | Sep 21, 2020 (4d) |
| Aug 17, 2020 | CHRS | ↓ Sell | 5,000 | $19.37 | $97K | Direct | Aug 19, 2020 (2d) |
| Jul 17, 2020 | CHRS | ↓ Sell | 15,000 | $18.25 | $274K | Direct | Jul 21, 2020 (4d) |
| Jun 17, 2020 | CHRS | ↓ Sell | 2,500 | $17.22 | $43K | Direct | Jun 19, 2020 (2d) |
| May 18, 2020 | CHRS | ↓ Sell | 3,093 | $17.17 | $53K | Direct | May 20, 2020 (2d) |
| Apr 20, 2020 | CHRS | ↓ Sell | 10,150 | $16.30 | $165K | Direct | Apr 21, 2020 (1d) |
| Feb 18, 2020 | CHRS | ↓ Sell | 7,500 | $21.64 | $162K | Direct | Feb 20, 2020 (2d) |
| Jan 17, 2020 | CHRS | ↓ Sell | 10,000 | $19.59 | $196K | Direct | Jan 22, 2020 (5d) |
| Dec 16, 2019 | CHRS | ↓ Sell | 2,500 | $18.69 | $47K | Direct | Dec 18, 2019 (2d) |
| Nov 14, 2019 | CHRS | ↓ Sell | 2,500 | $19.26 | $48K | Direct | Nov 18, 2019 (4d) |
| Oct 14, 2019 | CHRS | ↓ Sell | 2,500 | $18.40 | $46K | Direct | Oct 16, 2019 (2d) |
| Sep 16, 2019 | CHRS | ↓ Sell | 2,500 | $20.03 | $50K | Direct | Sep 18, 2019 (2d) |
| Aug 14, 2019 | CHRS | ↓ Sell | 2,500 | $19.00 | $48K | Direct | Aug 16, 2019 (2d) |
| Jul 15, 2019 | CHRS | ↓ Sell | 2,500 | $19.20 | $48K | Direct | Jul 17, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vincent R Anicetti's insider trades
Vincent R Anicetti is Chief Operating Officer at Coherus BioSciences (CHRS). Since Jul 15, 2019, Vincent has reported no open-market purchases and 22 sales worth $4.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (22 filings), grants and awards (7 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CHRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.